KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Resmed (RMD) Shares Outstanding (2016 - 2025)

Resmed (RMD) has disclosed Shares Outstanding for 13 consecutive years, with $188.1 million as the latest value for Q1 2022.

  • For the quarter ending Q1 2022, Shares Outstanding rose 549.62% year-over-year to $188.1 million, compared with a TTM value of $188.1 million through Mar 2022, up 549.62%, and an annual FY2021 reading of $187.5 million, changed 0.41% over the prior year.
  • Shares Outstanding was $188.1 million for Q1 2022 at Resmed, roughly flat from $188.0 million in the prior quarter.
  • Across five years, Shares Outstanding topped out at $188.1 million in Q1 2022 and bottomed at -$41.8 million in Q4 2018.
  • Average Shares Outstanding over 5 years is $92.4 million, with a median of $184.3 million recorded in 2018.
  • The sharpest move saw Shares Outstanding plummeted 122.7% in 2019, then soared 549.62% in 2022.
  • Year by year, Shares Outstanding stood at $185.1 million in 2018, then plummeted by 122.6% to -$41.8 million in 2019, then skyrocketed by 547.8% to $187.3 million in 2020, then increased by 0.38% to $188.0 million in 2021, then rose by 0.03% to $188.1 million in 2022.
  • Business Quant data shows Shares Outstanding for RMD at $188.1 million in Q1 2022, $188.0 million in Q4 2021, and $187.5 million in Q3 2021.